Catharina Svanborg

Catharina Svanborg

Net worth: 37 M $ as of 2026-05-30

77 year
Health Technology
Consumer Services
Commercial Services

Profile

Catharina Svanborg is the founder of Hamlet BioPharma AB, founded in 1999, holding the title of Chairman since 2025.
Dr. Svanborg is the founder of Linnane Pharma AB, founded in 2013, holding the title of Chairman since 2013.
Dr. Svanborg is the founder of SelectImmune Pharma AB, founded in 2017, holding the title of Chairman since 2017.
Dr. Svanborg currently holds the position of Director at the Royal Swedish Academy of Engineering Sciences since 1997.
Dr. Svanborg currently holds the position of Professor-Clinical Immunology at the University of Lund since 1989.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-06-29 45,976,673 ( 31.77% ) 37 M $ 2026-05-30

Catharina Svanborg active positions

CompaniesPositionStart
HAMLET PHARMA AB (PUBL) Founder 1999-03-28
SELECTIMMUNE PHARMA AB (PUBL) Chairman 2017-02-09
Corporate Officer/Principal 1988-12-31
Founder 2013-11-18
Director/Board Member 1996-12-31

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

85

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Catharina Svanborg
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!